 |
|
|
| |
High Medication Adherence in HCV-Infected Patients Taking a Triple-DAA Regimen for 12 Weeks
|
| |
| |
Reported by Jules Levin
AASLD 2013 Nov 1-4 Wash DC
Marc Bourliere1, Fred Poordad2, Bernard Vrijens3, Daniel Cohen4, Wangang Xie4, Marti n King4, Thomas Podsadecki4
1Hôpital Saint Joseph, Marseille, France; 2The Texas Liver Insti tute, University of Texas Health Science Center, San Antonio, Texas, United States; 3MWV Healthcare, Richmond, Virginia, United States; 4AbbVie Inc., North Chicago, Illinois, United States
|
| |
|
|
|
|
|
